TOP医療従事者の皆さまへ研究・業績(論文一覧)>2016年
医療従事者の皆さまへ
患者・ご家族の皆さまへ
医療従事者の皆さまへ
学生・研修医の皆さまへ

シンボルマーク

研究・業績(論文一覧) 2016年

英語論文邦文総説・著書邦文原著邦文その他
【英語論文】
  1. Mokutani Y, Uemura M, Munakata K, Okuzaki D, Haraguchi N, Takahashi H, Nishimura J, Hata T, Murata K, Takemasa I, Mizushima T, Doki Y, Mori M, Yamamoto H., Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer., Ann Surg Oncol, 2016
  2. Sueda T, Sakai D, Kawamoto K, Konno M, Nishida N, Koseki J, Colvin H, Takahashi H, Haraguchi N, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Satoh T, Doki Y, Mori M, Ishii H., BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells, Sci Rep, 2016
  3. Takahashi H, Suzuki Y, Nishimura J, Haraguchi N, Ohtsuka M, Miyazaki S, Uemura M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M., Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base., Int J Oncol, 48, 1, 115-22, 2016
  4. Mizushima T, Nakajima K, Takeyama H, Naito A, Osawa H, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M., Single-incision laparoscopic surgery for stricturing and penetrating Crohn's disease., Surg Today, 46, 2, 203-8, 2016
  5. Yasui M, Ikeda M, Miyake M, Ide Y, Okuyama M, Shingai T, Kitani K, Ikenaga M, Hasegawa J, Akamatsu H, Murata K, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M;, Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients., Am J Surg, 15, 2015
  6. Nishimura J, Hasegawa J, Ogawa Y, Miwa H, Uemura M, Haraguchi N, Hata T, Yamamoto H, Takemasa I, Mizushima T, Nezu R, Doki Y, Mori M, 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer., Surg Today, 46, 1152-1158, 2016
  7. Tamai K, Takemasa I, Uemura M, Nishimura J, Hata T, Higashihara H, Osuga K, Mizushima T, Yamamoto H, Doki Y, Mori M., Single-site laparoscopic colectomy for rectosigmoid cancer with middle aortic syndrome: report of a case., Surg Case Rep, 1, 1, 53, 2015
  8. Takeyama H, Mizushima T, Iijima H, Shinzaki S, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M., Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein., Dig Dis Sci, 60, 12, 3827, 2015
  9. Mokutani Y, Yamamoto H, Uemura M, Haraguchi N, Takahashi H, Nishimura J, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M., Effect of particle beam radiotherapy on locally recurrent rectal cancer: Three case reports., Mol Clin Oncol, 3, 4, 765-769, 2015
  10. Nonaka R, Miyake Y, Hata T, Kagawa Y, Kato T, Osawa H, Nishimura J, Ikenaga M, Murata K, Uemura M, Okuzaki D, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M., Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer., Int J Oncol, 47, 3, 1097-102, 2015
  11. Takeyama H, Mizushima T, Iijima H, Shinichiro S, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M., Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein., Dig Dis Sci., 60, 11, 3418-23, 2015
  12. Matsuda C, Uemura M, Nakata K, Shingai T, Nishimura J, Hata T, Ikenaga M, Takemasa I, Mizushima T, Kato T, Ikeda M, Ohue M, Murata K, Hasegawa J, Satoh T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M., Randomized phase II study of S-1 dosing schedule for resected colorectal cancer., BMC Cancer, 3, 15, 452, 2015
  13. Mizushima T, Tamagawa H, Matsuda C, Murata K, Fukunaga M, Ota H, Hasegawa J, Tsujie M, Fukuzaki T, Hata T, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M., Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer., Oncology., 89, 3, 152-8, 2015
  14. Nishimura J, Fukunaga M, Takemoto H, Nakata K, Ide Y, Fukuzaki T, Kudo T, Miyake Y, Yasui M, Morita S, Sakai D, Uemura M, Hata T, Takemasa I, Mizushima T, Ohno Y, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO)., Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial., Eur J Cancer, 51, 10, 1274-82, 2015
  15. Takahashi H, Nishimura J, Kagawa Y, Kano Y, Takahashi Y, Wu X, Hiraki M, Hamabe A, Konno M, Haraguchi N, Takemasa I, Mizushima T, Ishii M, Mimori K, Ishii H, Doki Y, Mori M, Yamamoto H., Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer, Mol Cancer Ther, 14, 7, 1705-16, 2015
  16. Ogawa H, Uemura M, Nishimura J, Hata T, Ikenaga M, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Yamamoto H, Doki Y, Mori M., Preoperative Chemoradiation Followed by Extensive Pelvic Surgery Improved the Outcome of Posterior Invasive Locally Recurrent Rectal Cancer without Deteriorating Surgical Morbidities: A Retrospective, Single-Institution Analysis., Ann Surg Oncol, 22, 13, 4325-34, 2015
  17. Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M, Nishida N, Uemura M, Hata T, Takemasa I, Mizushima T, Soh JW, Doki Y, Mori M, Yamamoto H., Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer., Mol Ther Nucleic Acids, 10, 4, e231, 2015
  18. Wu X, Yamamoto H, Nakanishi H, Yamamoto Y, Inoue A, Tei M, Hirose H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Hossain S, Akaike T, Matsuura N, Doki Y, Mori M., Innovative delivery of siRNA to solid tumors by super carbonate apatite., PLoS One, 10, 3, e0116022, 2015
  19. Osawa H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M., Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation., Int Surg, 100, 2, 358-64, 2015
  20. Naito A, Yamamoto H, Kagawa Y, Naito Y, Okuzaki D, Otani K, Iwamoto Y, Maeda S, Kikuta J, Nishikawa K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Ishii H, Doki Y, Mori M, Ishii M., RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells., J Biol Chem, 290, 10, 6326-37, 2015
  21. Takeyama H, Yamamoto H, Hata T, Takahashi Y, Ohtsuka M, Nonaka R, Inoue A, Naito A, Matsumura T, Uemura M, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M., A novel single-stapling technique for colorectal anastomosis: a pre-ligation single-stapling technique (L-SST) in a porcine model., Surg Endosc, 29, 8, 2371-6, 2015
  22. Inoue A, Yamamoto H, Uemura M, Nishimura J, Hata T, Takemasa I, Ikenaga M, Ikeda M, Murata K, Mizushima T, Doki Y, Mori M., MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer., Ann Surg Oncol, 22, 3, 1410-18, 2015
  23. Miyazaki S, Yamamoto H, Miyoshi N, Wu X, Ogawa H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Konno M, Doki Y, Mori M, Ishii H., A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer: Research for Reprogramming of Cancer Cells by MicroRNAs., Ann Surg Oncol, 22, 3, 1394-401, 2015
  24. Miyo M, Takemasa I, Mokutani Y, Uemura M, Nishimura J, Hata T, Mizushima T, Yamamoto H, Doki Y, Mori M., Single-incision laparoscopic rectopexy (Wells) with simultaneous sigmoidectomy in a case of complete rectal prolapse and a sigmoid tumor: report of a case., Surg Today, 45, 6, 793-8, 2015
  25. Miyo M, Yamamoto H., Konno M., Colvin H., Nishida N., Koseki J., Kawamoto K., Ogawa H., Hamabe A., Uemura M., Nishimura J., Hata T., Takemasa I., Mizushima T., Doki Y., Mori M., Ishii H., Tumour-suppressive function of SIRT4 in human colorectal cancer., Br J Cancer, 113, 3, 492-499, 2015
  26. Yamamoto H., Wu X., Nakanishi H., Yamamoto Y., Uemura M., Hata T., Nishimura J., Takemasa I., Mizushima T., Sasaki J., Imazato S., Matsuura N., Doki Y., Mori M., A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effects., Sci Rep, 5, 7742, 2015
  27. Kono T, Kondoh M, Kyuno D, Ito T, Kimura Y, Imamura M, Kohno T, Konno T, Furuhata T, Sawada N, Hirata K, Kojima T., Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway., Pharmacol Res Perspect., 20, 3, 2015
  28. Yamamoto H, Yamamoto H, Tomita N, Inomata M, Furuhata T, Miyake Y, Noura S, Kato T, Murata K, Hayashi S, Igarashi S, Itabashi M, Kameoka S, Matsuura N., OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan., Ann Surg Oncol. , 23, 2, 391-396, 2016
  29. Matsuda Y, Okita K, Furuhata T, Kutomi G, Yamashita K, Sato Y, Takimoto R, Hirata K., Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool., Support Care Cancer., 23, 11, 3331-3339, 2015
  30. Kukita K, Tamura Y, Tanaka T, Kajiwara T, Kutomi G, Saito K, Okuya K, Takaya A, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Furuhata T, Hirata K, Sato N., Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding., J Immunol., 194, 10, 4988-4996, 2015
  31. Furuhata T, Okita K, Nishidate T, Hirata K, Ohnishi H, Kobayashi H, Kotake K, Sugihara K; Study Group for Peritoneal Metastasis from Colorectal Cancer by the Japanese Society for Cancer of the Colon and Rectum., Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database., Int J Clin Oncol.
  32. Komatsu Y, Okita K, Yuki S, Furuhata T, Fukushima H, Masuko H, Kawamoto Y, Isobe H, Miyagishima T, Sasaki K, Nakamura M, Ohsaki Y, Nakajima J, Tateyama M, Eto K, Minami S, Yokoyama R, Iwanaga I, Shibuya H, Kudo M, Oba K, Takahashi Y., Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron., Cancer Sci, 106, 7, 891-895, 2015
  33. Keira Y, Takasawa A, Murata M, Nojima M, Takasawa K, Ogino J, Higashiura Y, Sasaki A, Kimura Y, Mizuguchi T, Tanaka S, Hirata K, Sawada N, and Hasegawa T
    An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens.
    Virchows Arch, 466:265-277, 2015 (IF: 2.651)
  34. Satomi F, Shima H, Mizuguchi T*, Torigoe T, Kutomi G, Kimura Y, Hirohashi Y, Tamura Y, Tsukahara T, Kanaseki T, Takahashi A, Asanuma H, Ito Y, Hayashi H, Sugita O, Sato N and Hirata K
    Phase I Clinical Study of Survivin-Derived Peptide Vaccine for Patients with Advanced Gastrointestinal Cancers.
    Int J Cancer Clin Res, 2:1, 2015
  35. Iwayama Y, Tsuruma T, Mizuguchi T, Furuhata T, Toyota N, Matsumura M, Torigoe T, Sato N, and Hirata K
    Prognostic value of HLA class I expression in patients with colorectal cancer.
    World J Surg Oncol, 13: 36, 2015 (IF: 1.408)
  36. Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, and Kato J
    A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 75:587-594, 2015 (IF: 2.769)
  37. Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, and Hirata K
    Prognostic roles of preoperative a-fetoprotein and des-g-carboxy prothrombin in hepatocellular carcinoma patients.
    World J Gastroenterol, 21:4933-45, 2015 (IF: 2.369)
  38. Meguro M, Mizuguchi T, Kawamoto M, Ota S, Ishii M, Nishidate T, Okita K, Kimura Y, and Hirata K
    Clinical comparison of laparoscopic and open liver resection after propensity matching selection.
    Surgery, 158:573-87, 2015 (IF: 3.38)
  39. Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F, Taniai N, Watanabe M, Katou M, Nagano H, Honda G, Baba H, Kokudo N, Konishi M, Hirata K, Yamamoto M, Uchiyama K, Uchida E, Kusachi S, Keiichi K, Mori M, Takahashi K, Kikuchi K, Miyata H, Takahara T, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, and Takada T
    Long-term and perioperative outcomes of laparoscopic vs open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    J Hepatobiliary Pancreat Sci. 22:711-20, 2015 (IF: 2.994)
  40. Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N, Hatano E, Tanahashi Y, Mizuguchi T, Kamiyama T, Ikeda T, Tanaka S, Taniai N, Baba H, Tanabe M, Kokudo N, Konishi M, Uemoto S, Sugioka A, Hirata K, Taketomi A, Maehara Y, Kubo S, Uchida E, Miyata H, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, and Takada T.
    Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
    J Hepatobiliary Pancreat Sci, 22:721-7, 2015 (IF: 2.994)
  41. Ishii M, Kimura Y, Sugita S, Imamura M, Ito T, Nobuoka T, Meguro M, Hasegawa T, Mizuguchi T, Hirata K.Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: A clinicopathological study of 184 resected cases.
    Pancreatology, 15:681-7, 2015. (IF: 2.837)
  42. Ishiyama G, Nishidate T, Ishiyama Y, Nishio A, Tarumi K, Kawamura M, Okita K, Mizuguchi T, Fujimiya M, Hirata K
    Anal cushion lifting method is a novel radical management strategy for hemorrhoids that does not involve excision or cause postoperative anal complications.
    World J Gastrointest Surg, 7:273-8, 2015.
  43. Harada K, Mizuguchi T*, Kawamoto M, Meguro M, Ota S, Sasaki S, Miyanishi K, Hatakenaka M, Shinomura Y, Kato J, and Hirata K
    Prediction of postoperative liver failure and evaluation of modified criteria for liver resection with computed volume analysis.
    Hepatogastroenterology, 2015 (in press) (IF: 0.928)
  44. Mizuguchi T*, Kawamoto M, Nakamura Y, Meguro M, Harada K, OtaS , Hui TT, and Hirata K
    New technique of extracorponeal hepatic inflow control for pure laparoscopic liver resection.
    Surg Laparosc Endosc Percutan Tech, 25:e16-20, 2015 (IF: 1.140)
  45. Mizuguchi T*, Kawamoto M, Meguro M, Okita K, Ota S, Ishii S, Ueki T, Kimura Y, Furuhata T, and Hirata K
    The impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis.
    Surg Today, 45:259-270, 2015 (IF: 1.526)
  46. Mizuguchi T*, Mitaka T, Hirata K
    Role of Branched Chain Amino Acids in Cellular and Organ Damage: The prognostic significance of the preoperative branched chain amino acid to tyrosine ratio.
    In Rajendram R, Preedy VR, Patel VB, eds. The branched chain amino acids in health and disease. pp65-77, London: Springer, 2015
  47. Mizuguchi T*, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, Hayashi H, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M, Miyamoto A, Hatakenaka M, Sato N, and Hirata K
    Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
    Surg Today, 46:139-48, 2016 (IF: 1.526)
  48. Okita K, Mizuguchi T*, Ota S, Ishii M, Nishidate T, Ueki T, Meguro M, Kimura Y, Tanimizu N, Ichinohe N, Torigoe T, Kojima T, Mitaka T, Sato N, Sawada N, and Hirata K
    Pancreatic regeneration: basic research and gene regulation
    Surg Today, 46:633-40, 2016 (IF: 1.526)
  49. Sakurada A, Hayashi T, Ono M, Ishiwatari H, Ogino J, Kimura Y, Kato J., A case of curatively resected gastric wall implantation of pancreatic cancer caused by endoscopic ultrasound-guided fine-needle aspiration., Endoscopy, 47, Suppl 1 UCTN, E198-9., 2015
  50. Ishii M, Kimura Y, Imamura M, Kyuno D, Ueki T, Uchiyama M, Mizuguchi T, Mukaiya M, Hirata K., Remnant pancreas reconstruction with duct-to-duct anastomosis after middle pancreatectomy: a report of two cases., Hepatogastroenterology, 62, 137, 190-4, 2015
  51. Kimura Y, Ito T, Imamura M, and Hirata K, Successful hybrid treatment for huge visceral artery aneurysms with contained rupture complicating segmental arterial mediolysis, Interact Cardiovasc Thorac Surg., 21, 6, 814-816, 2015
  52. Imamura M, Kimura Y, Ito T, Kyuno T, Nobuoka T, Mizuguchi T, Hirata K, Effects of antecolic versus retrocolic reconstruction for gastro/duodenojejunostomy on delayed gastric emptying after pancreatoduodenectomy: a systematic review and meta-analysis., J Surg Res, 2015 Aug 13. pii: S0022-4804(15)00821-5., 2015.08.004
  53. Ishii M, Kimura Y, Sugita S, Imamura M, Itoh T, Nobuoka T, Meguro M, Hasegawa T, Mizuguchi T, Hirata K, Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: a clinicopathological study of 184 resected cases, Pancreatology, 15, 681-687, 2015
  54. Isosaka M, Niinuma T, Nojima M, Kai M, Yamamoto E, Maruyama R, Nobuoka T, Nishida T, Kanda T, Taguchi T, Hasegawa T, Tokino T, Hirata K, Suzuki H, Shinomura Y., A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors., PLoS One., 27, 10, e0133754, 2015
  55. Mitsui Y, Sato Y, Miyamoto H, Fujino Y, Takaoka T, Miyoshi J, Kagawa M, Ohnuma H, Hirakawa M, Kubo T, Osuga T, Sagawa T, Sato Y, Takahashi Y, Katsuki S, Okuda T, Takimoto R, Kobune M, Nobuoka T, Hirata K, Kato J, Takayama T., Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy., Cancer Chemother Pharmacol., 17, 2, 375-82, 2015
  56. Takiguchi N, Takahashi M, Ikeda M, Inagawa S, Ueda S, Nobuoka T, Ota M, Iwasaki Y, Uchida N, Kodera Y, Nakada K., Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study., Gastric Cancer., 18, 2, 407-416, 2015
  57. Meguro M, Mizuguchi T, Kawamoto M, Ota S, Ishii M, Nishidate T, Okita K, Kimura Y, Hirata K., Clinical comparison of laparoscopic and open liver resection after propensity matching selection., Surgery, 158, 3, 573-587, 2015
  58. Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K., Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients., World J Gastroenterol., 21, 16, 4933-4945, 2015
  59. Maeda H, Kutomi G, Satomi F, Shima H, Mori M, Hirata K., Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration., Exp Ther Med., in press, 2016
  60. Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K, Current status of the prognostic molecular biomarkers in the breast cancer: A systematic review, Oncology Letters, in press, 2016
  61. Kukita K, Tamura Y, Tanaka T, Kajiwara T, Kutomi G, Saito K, Okuya K, Takaya A3, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Furuhata T, Hirata K, Sato N., Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding., J Immunol, 41043, 194, 4988-96, 2015
  62. Saito K, Kukita K, Kutomi G, Okuya K, Asanuma H, Tabeya T, Naishiro Y, Yamamoto M, Takahashi H, Torigoe T, Nakai A, Shinomura Y, Hirata K, Sato N, Tamura Y, Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE., Eur J Immunol, Jul, 45, 2028-41, 2015
  63. Matsuda Y, Okita K, Furuhata T, Kutomi G, Yamashita K, Sato Y, Takimoto R, Hirata K, Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool., Support Care Cancer, 40869, 23, 521445, 2015
  64. Tanaka T, Kajiwara T, Kutomi G, Kurotaki T3, Saito K, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Hirata K, Okamoto Y, Sato N, Tamura Y, CpG-A stimulates Hsp72 secretion from plasmacytoid dendritic cells, facilitating cross-presentation.Immunol Lett., Immunol Lett, Sep, 167, 34-40, 2015
  65. Kobayashi K, Sumikawa Y, Kikuchi Y, Kan Y, Kato J, Satomi F, Shima H, Kutomi G, Yamashita T., Synchronous Paget disease of the breast and axilla., J Am Acad Dermatol., 24837, 1, e44-5, 2015
  66. Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, Hayashi H, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M, Miyamoto A, Hatakenaka M, Sato N, Hirata K., Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?, Surg Today., Feb, 5, 2015
  67. Imamura M, Kimura Y, Ito T, Kyuno T, Nobuoka T, Mizuguchi T, Hirata K., Effects of antecolic versus retrocolic reconstruction for gastro/duodenojejunostomy on delayed gastric emptying after pancreatoduodenectomy: a systematic review and meta-analysis., J Surg Res, 200, 147-57, 2016
  68. Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, Tachibana M, Tanuma T, Maguchi H, Shinohara T, Hasegawa T, Imamura M, Kimura Y,Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y., Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis., Oncotarget, 6, 7209-20, 2015
  69. Ishii M,, Kimura Y, Sugita S, Imamura M, Ito T, Nobuoka T, Meguro M, Hasegawa T, Mizuguchi T,Hirata K., Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: A clinicopathological study of 184 resected cases., Pancreatology, 15, 681-7, 2015
  70. Kono T, Kondoh M, Kyuno D, Ito T, Kimura Y, Imamura M, Kohno T, Konno T, Furuhata T, Sawada N,Hirata K, Kojima T., Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway., Pharmacol Res Perspect, 3, e00196, 2015
  71. Kimura Y, Ito T, Imamura M, Hirata K., Successful hybrid treatment for huge visceral artery aneurysms with contained rupture complicating segmental arterial mediolysis., Interact Cardiovasc Thorac Surg, 21, 814-6, 2015
  72. Ishii M, Kimura Y, Imamura M, Kyuno D, Ueki T, Uchiyama M, Mizuguchi T, Mukaiya M, Hirata K., Remnant pancreas reconstruction with duct-to-duct anastomosis after middle pancreatectomy: a report of two cases. , Hepatogastroenterology, 62, 190-4, 2015
  73. Igarashi H, Kurihara H, Mitsuhashi K, Ito M, Okuda H, Kanno S, Naito T, Yoshii S, Takahashi H, Kusumi T, Hasegawa T, Sukawa Y, Adachi Y, Okita K, Hirata K, Imamura Y, Baba Y, Imai K, Suzuki H, Yamamoto H, Nosho K, Shinomura Y., Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer., Ann Surg Oncol, 22, 8, 2640-8, 2015
  74. Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J., A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer., Cancer Chemother Pharmacol, 75, 3, 587-94, 2015
  75. Nosho K, Igarashi H, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yoshii S, Mikami M, Takahashi H, Kusumi T, Hosokawa M, Sukawa Y, Adachi Y, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y., Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients., Digestion, 91, 1, 57-63, 2015
  76. Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, Hayashi H, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M, Miyamoto A, Hatakenaka M, Sato N, Hirata K., Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?, Surg Today, 46, 2, 139-48, 2015
  77. Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y., Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway., Int J Cancer., 137, 6, 1258-68, 2015
  78. Furuhata T, Okita K, Nishidate T, Hirata K, Ohnishi H, Kobayashi H, Kotake K, Sugihara K;, Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database., Int J Clin Oncol, 20, 5, 922-7, 2015
  79. Komatsu Y, Okita K, Yuki S, Furuhata T, Fukushima H, Masuko H, Kawamoto Y, Isobe H, Miyagishima T, Sasaki K, Nakamura M, Ohsaki Y, Nakajima J, Tateyama M, Eto K, Minami S, Yokoyama R, Iwanaga I, Shibuya H, Kudo M, Oba K, Takahashi Y, Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron., Cancer Sci., 106, 7, 891-5, 2015
  80. Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K., Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients., World J Gastroenterol, 21, 16, 4933-45, 2015
  81. Matsuda Y, Okita K, Furuhata T, Kutomi G, Yamashita K, Sato Y, Takimoto R, Hirata K., Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool., Support Care Cancer, 23, 11, 3331-9, 2015
  82. Takeuchi H, Saeki T, Aiba K, Tamura K, Aogi K, Eguchi K, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Udagawa Y, Okawa Y, Onozawa Y, Sasaki H, Shima Y, Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary. , Int J Clin Oncol, 21, 1, 1-12, 2016
  83. Meguro M, Mizuguchi T, Kawamoto M, Ota S, Ishii M, Nishidate T, Okita K, Kimura Y, Hirata K., Clinical comparison of laparoscopic and open liver resection after propensity matching selection., Surgery, 158, 3, 573-87, 2015
  84. Okita K, Mizuguchi T, Shigenori O, Ishii M, Nishidate T, Ueki T, Meguro M, Kimura Y, Tanimizu N, Ichinohe N, Torigoe T, Kojima T, Mitaka T, Sato N, Sawada N, Hirata K, Pancreatic regeneration: basic research and gene regulation., Surg Today, Epub Jul 7, 2015
  85. Ishiyama G, Nishidate T, Ishiyama Y, Nishio A, Tarumi K, Kawamura M, Okita K, Mizuguchi T, Fujimiya M, Hirata K., Anal cushion lifting method is a novel radical management strategy for hemorrhoids that does not involve excision or cause postoperative anal complications., World J Gastrointest Surg., 7, 10, 273-8, 2015
  86. Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K., The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway., Oncotarget., 7, 11, 12704-17, 2016
  87. Mayumi T, Yoshida M, Tazuma S, Furukawa A, Nishii O, Shigematsu K, Azuhata T, Itakura A, Kamei S, Kondo H, Maeda S, Mihara H, Mizooka M, Nishidate T, Obara H, Sato N, Takayama Y, Tsujikawa T, Fujii T, Miyata T, Maruyama I, Honda H, Hirata K, Practice Guidelines for Primary Care of Acute Abdomen 2015., J Hepatobiliary Pancreat Sci, 23, 1, 3-36, 2016
  88. Mayumi T, Yoshida M, Tazuma S, Furukawa A, Nishii O, Shigematsu K, Azuhata T, Itakura A, Kamei S, Kondo H, Maeda S, Mihara H, Mizooka M, Nishidate T, Obara H, Sato N, Takayama Y, Tsujikawa T, Fujii T, Miyata T, Maruyama I, Honda H, Hirata K., The Practice Guidelines for Primary Care of Acute Abdomen 2015., Jpn J Radiol. , 34, 1, 80-115, 2016
  89. Ishiyama G, Nishidate T, Ishiyama Y, Nishio A, Tarumi K, Kawamura M, Okita K, Mizuguchi T, Fujimiya M, Hirata K., Anal cushion lifting method is a novel radical management strategy for hemorrhoids that does not involve excision or cause postoperative anal complications., World J Gastrointest Surg., 7, 10, 273-8, 2015
  90. Takeuchi H, Saeki T, Aiba K, Tamura K, Aogi K, Eguchi K, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Udagawa Y, Okawa Y, Onozawa Y, Sasaki H, Shima Y, Shimoyama N, Takeda M, Nishidate T, Yamamoto A, Ikeda T, Hirata K., Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary., Int J Clin Oncol., 21, 1, 40919, 2016
  91. Mizuguchi T, Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, HayashiH, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M,Miyamoto A, Hatakenaka M, Sato N, Hirata K., Trials of vaccines for pancreaticductal adenocarcinoma: Is there any hope of an improved prognosis?, Surg Today, 46, 2, 139-148, 2016
  92. Kobayashi K, Sumikawa Y, Kikuchi Y, Kan Y, Kato J, Satomi F, Shima H, Kutomi, G, Yamashita T. Synchronous Paget disease of the breast and axilla., Synchronous Paget disease of the breast and axilla., J Am Acad Dermatol, 72, 1, e44-45, 2016
  93. Kutomi G, Ohmura T, Satomi F, Maeda H, Shima H, Kameshima H, Okazaki M, Masuoka H, Sasaki K, Hirata K., A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer., Int J Clin Oncol, 20, 3, 474-479, 2015
  94. Kyan R, Uemura S, Tanno K, Sawamoto K, Harada K, Sakawaki E, Fujita Y, Endo S, Narimatsu E., Severe accidental colchicine poisoning by the autumn crocus: A case of successful treatment., J Acute Medicine, 5, 4, 103-106, , 2015
  95. Kyuno D, Ohno K, Katsuki S, Fujita T, Konno A, Murakami T, Waga E, Takanashi K, Kitaoka K, Komatsu Y, Sasaki K, Hirata K., Laparoscopic-endoscopic cooperative surgery is a safe and effective treatment for superficial nonampullary duodenal tumors., Asian journal of endoscopic surgery, 8, 4, 461-464, 2015, Asian J Endosc Surg. 
  96. Tsuyoshi Kono, Masuo Kondoh, Daisuke Kyuno, Tatsuya Ito, Yasutoshi Kimura, Masafumi Imamura, Takayuki Kohno, Takumi Konno, Tomohisa Furuhata, Norimasa Sawada, Koichi Hirata and Takashi Kojima, Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway, Pharmacology Research & Perspectives, 3, 6, e00196, 2015
  97. Ishii M, Kimura Y, Imamura M, Kyuno D, Ueki T, Uchiyama M, Mizuguchi T, Mukaiya M, Hirata K., Remnant pancreas reconstruction with duct-to-duct anastomosis after middle pancreatectomy: a report of two cases, Hepatogastroenterology, 62, 137, 190-4, 2015
  98. Ishii M, Kimura Y, Sugita S, Imamura M, Ito T, Nobuoka T, Meguro M, Hasegawa T, Mizuguchi T, Hirata K., Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: A clinicopathological study of 184 resected cases., Pancreatology, 15, 6, 681-7, 2015

▲ページTOPへ
【邦文総説・著書】
  1. 竹政 伊知朗, 森 正樹, ここまで来た!直腸癌に対する低侵襲手術TEM, 消化器外科, 38, 12, 1649-1660, 2015
  2. 竹政 伊知朗, 水島 恒和, 土岐 祐一郎, 森 正樹, 「State of the art」SILS, 大腸がんperspective, 2, 3, 192-198, 2015
  3. 竹政 伊知朗, 森 正樹, 『最新主要文献と解説』単孔式手術とReduced Port Surgery, 消化器外科学レビュー2015-'16, 159-163, 2015
  4. 竹政 伊知朗, 山本 浩文, 土岐 祐一郎, 森 正樹, 【最新臨床大腸癌学-基礎研究から臨床応用へ-】 大腸癌の検査・診断 原発巣の診断 Multi-image 3D fusion virtual画像による術前診断-よりよい手術のために-, 日本臨床, 73, 増刊4, 302-307, 2015
  5. 竹政 伊知朗, 植村 守, 西村 潤一, 水島 恒和, 山本 浩文, 土岐 祐一郎, 森 正樹, 【大腸癌診療のトピックス2015】単孔式/reduced port surgery, 消化器外科, 38, 2, 165-174, 2015
  6. 呉鑫, 山本浩文、畑泰司、西村潤一、竹政伊知朗、水島恒和、土岐祐一郎、森正樹, Question 76 細菌叢が癌微小環境に与える影響と治療反応性について教えてください, Surgery Frontier, 22, 1, 78-80, 2015
  7. 畑泰司, 竹政伊知朗、植村守、西村潤一、水島恒和、山本浩文、土岐祐一郎、森正樹, 4.肛門管癌浸潤の画像診断とISRの適応, 外科, 77, 3, 264-269, 2015
  8. 大塚正久, 畑泰司、平木将之、竹山廣志、野中亮児、植村守、西村潤一、竹政伊知朗、水島恒和、山本浩文、土岐祐一郎、森正樹, 直腸巨大絨毛腺腫に癌を合併し広範なリンパ節転移を認めた1例, 癌と化学療法, 42, 6, 747-750, 2015
  9. 内藤敦, 賀川義規、竹政伊知朗、水島恒和、山本浩文、土岐祐一郎、森正樹, 解明されつつある細胞周期の調節機構, 大腸がんperspective, 2, 1, 59-93, 2015
  10. 山本浩文, 今野雅允、植村守、西村潤一、畑泰司、竹政伊知朗、水島恒和、Hugh Colvin、西田尚弘、川本弘一、小関準、土岐祐一郎、森正樹、石井秀始, 癌における解糖系酵素の制御とその働き, 大腸がんperspective , 2, 3, 217-221, 2015
  11. 古畑 智久, 沖田 憲司, 西舘 敏彦, 植木 知身, 秋月 恵美, 平田 公一, 若手に伝えるヘモ・ヘルニア手術 腹壁瘢痕ヘルニア手術におけるエビデンス, 北海道外科雑誌, 60, 1, 18-22, 2015
  12. 古畑 智久, 沖田 憲司, 西舘 敏彦, 大腸癌の予後因子 血清CEA値は大腸癌の予後因子となりうるか(術前・術後、再発時), 日本臨床, 73, 4, 219-222, 2015
  13. 佐野 圭二, 古畑 智久, 大腸癌肝転移の手術適応, 日本医事新報. 4751, 55-56, 2015
  14. 古畑 智久, 大腸癌に対する最新の手術, 札幌保健科学雑誌, 5, 40916, 2016
  15. 平田公一, 信岡隆幸、巽 博臣、荒川朋子、秋月恵美、今村将史、木村康利、及能大輔、太田盛道、小川宰司、沖田憲司、水口 徹, 生活習慣と胆のう癌、胆管癌, Modern Physician, 30, 10, 1243-1250, 2015
  16. 目黒 誠, 水口 徹, 沖田 憲司, 西舘 敏彦, 植木 知身, 秋月 恵美, 及能 大輔, 信岡 隆幸, 木村 康利, 平田 公一, NASHと腸内細菌叢, Surgery Frontier, 22, 3, 250-254, 2015
  17. 升田好樹, 巽 博臣, 心臓血管外科術後患者の輸液管理のポイント~知っておくべき心臓外科術後の病態生理と輸液管理.特集1 侮れない輸液の基本(電解質補正)と注意点, 達人ナース, 36, 4, 31-40, 2015
  18. 巽 博臣, 升田好樹、吉田真一郎, 経腸栄養のモニタリング.III 経腸栄養の実際.重症病態の栄養治療-最新の知識とその実践-, 救急集中治療, 27, 7-8, 543-547, 2015
  19. 巽 博臣, 升田好樹、数馬 聡, 経腸栄養時の誤嚥の予防策.III経腸栄養の実際.重症病態の栄養治療-最新の知識とその実践-, 救急集中治療, 27, 7-8, 548-552, 2015
  20. 巽 博臣, 升田好樹、後藤京子、高橋科那子, 経腸栄養に関連する下痢と排便コントロール.III経腸栄養の実際.重症病態の栄養治療-最新の知識とその実践-, 救急集中治療, 27, 7-8, 553-556, , 2015
  21. 升田好樹, 巽 博臣、今泉 均, ステロイド.重症敗血症ではパルス療法を行わない.敗血症性ショックには「ハイドロコルチゾン200mg/dayの持続投与」を「早期」から行う.sepsis・SIRS-その常識は正しいか?-, 救急集中治療, 27, 11-12, 935-944, 2015
  22. 巽 博臣, 2.こんなときどうする? ② ~嘔吐・下痢・便秘のとき.第2章 困ったときの栄養管理~差がつくテクニック.栄養療法がわかる! できる! プレゼンのカリスマから学ぶ基本知識と症例問題で身につく実践力で、治療がグッとうまくいく!, レジデントノート増刊, 17, 17, 3172-3180, 2016
  23. 今村将史, 木村康利, 伊東竜哉, 河野剛, 信岡隆幸, 目黒誠, 古畑智久, 水口徹., 【胆・膵疾患に対する外科治療】肝胆膵領域に対する外科治療 膵癌に対する外科治療., 北海道外科雑誌, 60, 114-119, 2015
  24. 木村康利, 今村将史, 伊東竜哉, 及能拓朗, 信岡隆幸, 目黒誠, 水口徹, 平田公一., 上部消化管あるいは膵に対する手術既往のある症例に対する膵手術., 消化器外科, 38, 57-67, 2015
  25. 木村康利, 今村将史, 伊東竜哉, 沖田憲司, 目黒誠, 信岡隆幸, 水口徹, 古畑智久, 平田公一., 膵臓外科のトピックス-膵癌に対する集学的治療の進歩-., 北海道外科雑誌, 第100回記念号, 72-9, 2015
  26. 河野剛, 木村康利, 今村将史, 伊東竜哉, 及能拓朗, 信岡隆幸, 目黒誠, 水口徹, 平田公一., 【わかりやすい消化器癌治療のコンセンサス】 膵癌の診断と治療 NETの治療戦略., 消化器外科, 38, 847-853, 2015
  27. 水口徹, 目黒誠, 沖田憲司, 西舘敏彦, 信岡隆幸, 今村将史, 河野豊, 高木秀安, 佐々木茂, 宮西浩嗣, 加藤淳二, 平田公一., 【危惧する感染症-院内感染防止対策-】B型肝炎ウイルス感染症に関する最近の動向., Surgery Frontier, 22, 221-226, 2015
  28. 平田公一, 信岡隆幸, 巽博臣, 荒川朋子, 秋月恵美, 今村将史, 木村康利, 及能大輔, 太田盛道, 小川宰司, 沖田憲司, 水口徹., 【生活習慣病と消化器疾患】 生活習慣と胆のう癌、胆管癌.,Modern Physician, 35, 1243-1249 , 2015
  29. 沖田憲司, 古畑 智久, 西舘 敏彦, 目黒 誠, 信岡 隆幸, 木村 康利, 水口 徹, 平田 公一, 【下部消化管疾患に対する外科治療】 下部消化管に対する外科治療, 北海道外科雑誌, 60, 1, 18-22, , 2015
  30. 増岡 秀次, 九冨 五郎, 三神 俊彦, 桜井 美紀, 藤澤 純子, 吉田 佳代, 白井 秀明, 下川原 出, 浅石 和昭, 島 宏彰, 前田 豪樹, 大村 東生, 亀嶋 秀和, 三原 大佳, 野村 直弘, 森 満, "受けてよかった乳がん検診"にするための工夫 精査施設における乳がん検診 診断から治療まで, 日本乳癌検診学会誌, 25, 1, 20-26, 2016
  31. 河野 剛, 木村康利、今村将史、伊東 竜哉、及能 拓朗、信岡 隆幸、目黒 誠、水口 徹、平田 公一, NETの治療戦略, 消化器外科, 38, 5, 847-853, 2015
  32. 里見蕗乃, 島 宏彰、水口 徹、鳥越俊彦、九冨五郎、木村康利、廣橋良彦、田村保明、塚原智英、金関貴幸、高橋あかり、浅沼広子、伊藤陽一、林宏至、杉田修、佐藤昇志、平田公一, 有効な治療法のない進行消化器がん患者に対するSVN-2B単独投与の第Ⅰ相臨床試験, 北海道外科雑誌, 60, 2, 69-71, 2015

▲ページTOPへ
【邦文原著】
  1. 吉野 淳一, 後藤 葉子, 佐藤 公美子, 根木 亨, 中村 充雄, 中井 夏子, 長多 好恵, 横山 まどか, 大塚 知子, 古名 丈人, 池田 望, 齋藤 重幸, 古畑 智久, 松村 博文, 保健医療総論1における学生へのアンケートを用いた学習効果に関する検討, 札幌保健科学雑誌, 4, 73-78, 2015
  2. 急性膵炎診療ガイドライン2015改訂出版委員会, 分担執筆, 木村康利担当箇所;診断(血液・尿検査), 急性膵炎診療ガイドライン2015(第4版), 金原出版, 東京, 2015
  3. 日本神経内分泌腫瘍研究会(JNET), 分担執筆, 木村康利担当箇所;消化管NETの外科治療, 膵・消化管神経内分泌腫瘍 (NET)診療ガイドラン, 金原出版, 東京, 2015
  4. 伊東竜哉, 木村康利, 今村将史, 目黒誠, 信岡隆幸, 水口徹, 平田公一., 六君子湯投与の膵頭十二指腸切除術後胃排出遅延に与える影響., 胆膵の病態生理, 31, 35-42, 2015
  5. 木村康利, 今村将史, 伊東竜哉, 加藤淳二, 長谷川匡, 平田公一., 放射線化学療法後に根治術を施行した切除不適格胆道癌症例の解析., 日本臨床外科学会雑誌, 76, 1553-1561, 2015
  6. 増岡 秀次, 九冨 五郎, 三神 俊彦, 藤澤 純子, 桜井 美紀, 吉田 佳代, 白井 秀明, 下川原 出, 浅石 和昭, 島 宏彰, 前田 豪樹, 大村 東生, 亀嶋 秀和, 三原 大佳, 野村 直弘, 森 満, ハイリスク女性に対する検診をどうするか ハイリスク女性に対する検診の勧奨, 日本乳癌検診学会誌, 24, 2, 215-222, 2015
  7. 及能大輔, 大野敬祐、佐々木一晃、今野愛、村上武志、平田公一, 腹腔鏡がヘルニアの同定と修復に有用であった大腿ヘルニア嵌頓の1例, 臨床外科, 70, 4, 486-490, 2015, 臨外

▲ページTOPへ
【邦文その他】
  1. 古畑智久, 解剖学ノートを拝見して, 標本館だより, 44, 41003, 2016
  2. 信岡隆幸, 一般社団法人日本静脈経腸栄養学会専門療法士認定委員会, NST専門療法士認定試験 過去問題集I, 南江堂, 2016
  3. 荒川朋子, 巽 博臣、秋月恵美、白石沙耶可、茅原悦子、三木彩子、高橋和也、舘山三紀子、望月真希、水野愛理、信岡隆幸、平田公一, 頻回の低血糖や嘔吐を伴った小児の経空腸栄養管理症例に対するREF-P1®の有用性, ヒューマンニュートリション, 7, 3, 40-47, 2015
  4. 長南新太, 升田好樹、巽 博臣、数馬 聡、後藤京子、高橋科那子、宮島正博、今泉 均, ビデオ胸腔鏡下手術による頻回のドレナージにより救命し得た降下性壊死性縦隔炎の1例, 麻と蘇生, 51, 1-2, 1-4, , 2015
  5. 君島知彦, 升田好樹、今泉 均、巽 博臣、後藤京子、喜屋武玲子、山蔭道明, 妊娠経過中に発症した劇症1型糖尿病の1例, 日集中医誌, 22, 4, 273-274, 2015
  6. 君島知彦, 升田好樹、巽 博臣、後藤京子、名和由布子、山 直也、山蔭道明、今泉 均, 経皮的気管切開術施行時の腕頭動脈異常走行例の経験, 日集中医誌, 23, 2, 179-180, 2016
  7. 九冨 五郎, 久木田 和晴, 里見 蕗乃, 前田 豪樹, 島 宏彰, 水口 徹, 平田 公一, バイオマーカーをめぐるQ&A(Question 16) hERO1-Lα発現による乳癌予後予測は可能か?, Surgery Frontier, 22, 3, 283-285, 2015

▲ページTOPへ